Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07406893 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reduction of Bacterial Seeding in Total Shoulder Arthroplasty

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary endpoint revised
    • Start date changed from estimate of Mar 2026 to Feb 23, 2026
    • Site details revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to compare the growth of intra-operative tissue cultures of Cutibacterium Acnes after primary shoulder replacement when using a no-prep control group versus Prontosan wound gel applied to the skin layer after the skin incision has been made.
Trial Details
NCT Number NCT07406893
Lead Sponsor St. Louis University
Collaborators: Innovice, LLC, American Shoulder and Elbow Surgeons
Conditions
(from sponsor)		 Joint Arthroplasty, Shoulder, Cutibacterium Acnes, Prosthetic Joint Infection
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov